Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Ovarian Neoplasms 2Sarcoma 1Radiation Pneumonitis 1Pancreatic Neoplasms 1Mesothelioma, Malignant 1Mesothelioma 1Inflammatory Breast Neoplasms 1Glioblastoma 1Colorectal Neoplasms 1Breast Neoplasms 1Appendiceal Neoplasms 1

Interventions

Oxaliplatin 2nintedanib 1motexafin lutetium 1Palonosetron 1Irinotecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Appendiceal Neoplasms × nintedanib × Clear all
NCT03287947 2022-08-09

LCI-GI-APX-NIN-001: Nintedanib in Metastatic Appendiceal Carcinoma

Wake Forest University Health Sciences

Phase 2 Terminated
5 enrolled 12 charts
Gastrointestinal

Appendiceal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡